Anzeige
Mehr »
Freitag, 27.06.2025 - Börsentäglich über 12.000 News
Blockbuster-Bohrergebnisse: Gold-Antimon-Fund in Nevada trifft geopolitischen Nerv
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PNGL | ISIN: US08862L1035 | Ticker-Symbol: 48L
Tradegate
25.06.25 | 19:18
0,146 Euro
+3,55 % +0,005
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
BEYOND AIR INC Chart 1 Jahr
5-Tage-Chart
BEYOND AIR INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,1290,14016:44
0,1290,14016:43

Aktuelle News zur BEYOND AIR Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiBeyond Air-Aktionäre genehmigen Reverse-Aktiensplit4
BEYOND AIR Aktie jetzt für 0€ handeln
20.06.Beyond Air, Inc. - 10-K, Annual Report3
18.06.Beyond Air, Inc. - 8-K, Current Report3
17.06.Beyond Air Stock Dips After Mixed Q4 Results: Here's What To Know6
17.06.Beyond Air: EPS übertrifft Schätzungen um 0,06 $ - Umsatz schlechter als erwartet4
17.06.Beyond Air GAAP EPS of -$0.09 beats by $0.03, revenue of $1.15M misses by $0.24M1
17.06.Beyond Air Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update164Revenues increased 220% to $3.7 million, compared with $1.2 million for the fiscal year ended March 31, 2024 Expect to report revenue of at least $1.7 million for quarter ending June 30, 2025, and...
► Artikel lesen
16.06.Beyond Air Submits FDA PMA Supplement for Next Generation LungFit PH4
16.06.Top Wall Street Forecasters Revamp Beyond Air Expectations Ahead Of Q4 Earnings4
24.04.Beyond Air Granted U.S. Patent Covering Treatment of NTM Infections Using gaseous Nitric Oxide (gNO)9
21.04.Beyond Air: NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism424The FDA designation marks a significant milestone in the development of a novel treatment for a rare neurodevelopmental disorder Plan to initiate first-in-human U.S. clinical trials of lead drug candidate...
► Artikel lesen
15.04.Beyond Air: NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board19
09.04.Beyond Air Publishes Article in Annals of the American Thoracic Society Journal Highlighting NTM-PD Patients' Ability to Safely Self-Administer High-Dose Intermittent iNO Treatments Using the LungFit GO at Home2
31.03.Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site3
24.03.Beyond Air: NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy1
14.03.Beyond Air, Inc. - 8-K, Current Report1
11.03.Beyond Air Expands LungFit PH With Distribution Deals In 4 Countries; Stock Up In Pre-market7
11.03.Beyond Air expands global reach with new distribution deals4
11.03.Beyond Air Announces Agreements Expanding Global Distribution of LungFit PH2
14.02.Beyond Air, Inc. - 8-K, Current Report-
Weiter >>
31 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1